13F Filings for MPM ASSET MANAGEMENT LLC (CIK: 1263048)
View the most recent portfolio holdings disclosed by MPM ASSET MANAGEMENT LLC in their 13F filing.
Holding | Shares | Value | Portfolio Percent | Change Status | Change Amount |
---|---|---|---|---|---|
TRDA - Entrada Therapeutics, Inc.(Class: Common) | 4.38M | $29.44M | 67.92% | Unchanged | |
DYN - Dyne Therapeutics, Inc.(Class: Common) | 682.38K | $6.50M | 14.99% | Unchanged | |
HOWL - Werewolf Therapeutics, Inc.(Class: Common) | 4.31M | $4.70M | 10.84% | Unchanged | |
RPTX - Repare Therapeutics, Inc.(Class: Common) | 1.12M | $1.56M | 3.60% | Unchanged | |
ADAP - Adaptimmune Therapeutics plc(Class: Sponsored ADS) | 4.81M | $1.15M | 2.66% | Decreased | 526.04K (9.0%, $101.74K) |
ITOS - iTeos Therapeutics, Inc.(Class: Common) | 0 | $0 | - | Exited | 2.74M ($16.35M) |